{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:27:24Z","timestamp":1791120444267,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinate synthase gene (ALAS2). XLSA was diagnosed in a 32-year-old woman with a mild phenotype and moderately late onset. Pyridoxine therapy had no effect in the proband, but in her affected son engendered a modest increase in hemoglobin concentration and a 4-fold reduction in ferritin iron. Molecular analysis identified a C to G transversion at nucleotide -206 from the transcription start site, as defined by primer extension, in the proximal promoter region of ALAS2. No other mutations were found in the promoter region, the flanking intronic sequences, the exons, or the 3\u2032 genomic region. The same mutation was found in her affected son but not in any other of her unaffected relatives. The mutation resulted in a 94% loss of activity relative to the wild-type sequence for a luciferase reporter construct containing the proximal 293 nucleotides (nt's) of the ALAS2 promoter when transfected into human erythroid K562 cells. Confirming the mutation's deleterious effect, the ALAS2 mRNA level in the proband's erythroid precursors was reduced 87%. The mutation occurred in or near 3 different putative transcription factor binding sites of unknown erythroid importance. The dramatic decreases in reporter activity and mRNA level suggest that the region of the mutation may bind a novel and important erythroid regulatory element.<\/jats:p>","DOI":"10.1182\/blood-2002-06-1623","type":"journal-article","created":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T01:26:35Z","timestamp":1049160395000},"page":"698-704","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia"],"prefix":"10.1182","volume":"102","author":[{"given":"Soumeya","family":"Bekri","sequence":"first","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"May","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Cotter","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala I.","family":"Al-Sabah","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Guo","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian S.","family":"Masters","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Bishop","sequence":"additional","affiliation":[{"name":"From the Department of Human Genetics, Mount Sinai School of Medicine, New York, NY; the Laboratoire d'He\u0301pato-Gastroente\u0301rologie et Nutrition-Faculte\u0301 de Me\u0301decine de Nice, Centre Universitaire de Nice, Nice, France; and the Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021300234298800_REF1","unstructured":"Online Mendelian Inheritance in Man, OMIM. Johns Hopkins University: Baltimore, MD. MIM number: 301300:11\/24\/2001. Available at: http:\/\/www.ncbi.nlm.nih.gov\/Omim\/. Accessed October 2002."},{"key":"2020021300234298800_REF2","doi-asserted-by":"crossref","unstructured":"Cotter PD, Baumann M, Bishop DF. Enzymatic defect in \u201cX-linked\u201d sideroblastic anemia: molecular evidence for erythroid \u03b4-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A. 1992; 89: 4028-4032.","DOI":"10.1073\/pnas.89.9.4028"},{"key":"2020021300234298800_REF3","doi-asserted-by":"crossref","unstructured":"Cotter PD, Rucknagel DL, Bishop DF. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific \u03b4-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley. Blood. 1994;84: 3915-3924.","DOI":"10.1182\/blood.V84.11.3915.bloodjournal84113915"},{"key":"2020021300234298800_REF4","doi-asserted-by":"crossref","unstructured":"Cox TC, Bottomley SS, Wiley JS, Bawden MJ, Matthews CS, May BK. X-Linked pyridoxine-responsive sideroblastic anemia due to a THR388-to-SER substitution in erythroid 5-aminolevulinate synthase. New Engl J Med.1994;330: 675-679.","DOI":"10.1056\/NEJM199403103301004"},{"key":"2020021300234298800_REF5","unstructured":"May A, Bishop D. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia. Haematologica. 1998;83: 56-70."},{"key":"2020021300234298800_REF6","doi-asserted-by":"crossref","unstructured":"Cotter PD, May A, Li L, et al. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis. Blood. 1999;93: 1757-1769.","DOI":"10.1182\/blood.V93.5.1757"},{"key":"2020021300234298800_REF7","unstructured":"Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol 2. 8th ed. New York, NY: McGraw-Hill; 2001: 2991-3062."},{"key":"2020021300234298800_REF8","doi-asserted-by":"crossref","unstructured":"Edgar AJ, Wickramasinghe SN. Hereditary sideroblastic anaemia due to a mutation in exon 10 of the erythroid 5-aminolaevulinae synthase gene. Br J Haematol. 1998;100: 389-392.","DOI":"10.1046\/j.1365-2141.1998.00569.x"},{"key":"2020021300234298800_REF9","doi-asserted-by":"crossref","unstructured":"Cotter PD, May A, Fitzsimons EJ, et al. Late onset X-linked sideroblastic anemia: missense mutations in the erythroid \u03b4-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory sideroblastic anemia and ringed sideroblasts (RARS). J Clin Invest. 1995;96: 2090-2096.","DOI":"10.1172\/JCI118258"},{"key":"2020021300234298800_REF10","doi-asserted-by":"crossref","unstructured":"Cazzola M, May A, Bergamaschi G, Cerani P, Rosti V, Bishop DF. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood. 2000;96: 4363-4365.","DOI":"10.1182\/blood.V96.13.4363"},{"key":"2020021300234298800_REF11","unstructured":"Cavill I, Ricketts C. Human iron kinetics. In: Jacobs A, Worwood M, eds. Iron in Biochemistry and Medicine II. London, England: Academic Press; 1980: 573-604."},{"key":"2020021300234298800_REF12","unstructured":"Piomelli S. A micromethod for free erythrocyte porphyrins: the FEP test. J Lab Clin Med.1973; 81: 932-940."},{"key":"2020021300234298800_REF13","doi-asserted-by":"crossref","unstructured":"Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human \u03b1-galactosidase A gene: further evidence for the absence of the 3\u2032 untranslated region. Proc Natl Acad Sci U S A. 1988;85: 3903-3907.","DOI":"10.1073\/pnas.85.11.3903"},{"key":"2020021300234298800_REF14","doi-asserted-by":"crossref","unstructured":"Bishop DF. Two different genes encode \u03b4-aminolevulinate synthase in humans: nucleotide sequences of cDNAs for the housekeeping and erythroid genes. Nucl Acids Res.1990;18: 7187-7188.","DOI":"10.1093\/nar\/18.23.7187"},{"key":"2020021300234298800_REF15","doi-asserted-by":"crossref","unstructured":"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74: 5463-5467.","DOI":"10.1073\/pnas.74.12.5463"},{"key":"2020021300234298800_REF16","doi-asserted-by":"crossref","unstructured":"Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolators of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18: 5294-5299.","DOI":"10.1021\/bi00591a005"},{"key":"2020021300234298800_REF17","unstructured":"Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: a Laboratory Manual (1st ed). Cold Spring Harbor, NY; 1982."},{"key":"2020021300234298800_REF18","unstructured":"Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning: A laboratory manual. Vol. 1. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989."},{"key":"2020021300234298800_REF19","doi-asserted-by":"crossref","unstructured":"Masters GS, Burnett AK. Serum-free culture of human megakaryocyte progenitors. Clin Lab Haematol. 1997;19: 61-65.","DOI":"10.1046\/j.1365-2257.1997.00193.x"},{"key":"2020021300234298800_REF20","unstructured":"Applied Biosystems User Bulletin no. 2: ABI PRISM 7700 Sequence Detection System. Applied Biosystems: Weiterstadt, Germany. December 11, 1997. Available at: http:\/\/www.ukl.uni-freiburg.de\/core-facility\/taqman\/user_bulletin_2.pdf. Accessed October 2002."},{"key":"2020021300234298800_REF21","doi-asserted-by":"crossref","unstructured":"Cox TC, Bawden MJ, Martin A, May BK. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J.1991;10: 1891-1902.","DOI":"10.1002\/j.1460-2075.1991.tb07715.x"},{"key":"2020021300234298800_REF22","doi-asserted-by":"crossref","unstructured":"Krawczak M, Cooper DN. The human gene mutation database. Trends Genet. 1997;13: 121-122.","DOI":"10.1016\/S0168-9525(97)01068-8"},{"key":"2020021300234298800_REF23","unstructured":"Semenza GL. Transcription factors and human disease. New York, NY: Oxford University Press; 1999."},{"key":"2020021300234298800_REF24","unstructured":"Antonarakis SE, Krawczak, Cooper DN. The nature and mechanisms of human gene mutation. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol 1. 8th ed. New York, NY: McGraw-Hill; 2001: 343-377."},{"key":"2020021300234298800_REF25","doi-asserted-by":"crossref","unstructured":"Matsuda M, Sakamoto N, Fukumaki Y. Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter. Blood. 1992; 80: 1347-1351.","DOI":"10.1182\/blood.V80.5.1347.1347"},{"key":"2020021300234298800_REF26","doi-asserted-by":"crossref","unstructured":"Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J Clin Invest. 2001;107: 753-762.","DOI":"10.1172\/JCI10642"},{"key":"2020021300234298800_REF27","doi-asserted-by":"crossref","unstructured":"Bonkovsky HL, Barnard GF. Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology. Semin Liver Dis.1998;18: 57-65.","DOI":"10.1055\/s-2007-1007141"},{"key":"2020021300234298800_REF28","unstructured":"Horrigan DL, Harris JW. Pyridoxine-responsive anemia: analysis of 62 cases. Adv Int Med.1964; 12: 103-174."},{"key":"2020021300234298800_REF29","doi-asserted-by":"crossref","unstructured":"Prestridge, DS. SIGNAL SCAN: A computer program that scans DNA sequences for eukaryotic transcriptional elements. CABIOS. 1991;7: 203-206.","DOI":"10.1093\/bioinformatics\/7.2.203"},{"key":"2020021300234298800_REF30","doi-asserted-by":"crossref","unstructured":"James R, Erler T, Kazenwadel J. Structure of the murine homeobox gene cdx-2: expression in embryonic and adult intestinal epithelium. J Biol Chem.1994;269: 15229-15237.","DOI":"10.1016\/S0021-9258(17)36596-1"},{"key":"2020021300234298800_","doi-asserted-by":"crossref","unstructured":"Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol.1996;16: 619-625.","DOI":"10.1128\/MCB.16.2.619"},{"key":"2020021300234298800_REF32","doi-asserted-by":"crossref","unstructured":"Fang R, Santiago NA, Olds LC, Sibley E. The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation. Gastroenterology. 2000;118: 115-127.","DOI":"10.1016\/S0016-5085(00)70420-3"},{"key":"2020021300234298800_REF33","doi-asserted-by":"crossref","unstructured":"Giguere V, Tini M, Flock G, Ong E, Evans RM, Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev.1994;8: 538-553.","DOI":"10.1101\/gad.8.5.538"},{"key":"2020021300234298800_REF34","doi-asserted-by":"crossref","unstructured":"Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev.2001;81: 1269-1304.","DOI":"10.1152\/physrev.2001.81.3.1269"},{"key":"2020021300234298800_REF35","doi-asserted-by":"crossref","unstructured":"Kato S, Sasaki H, Suzawa M, et al. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol Cell Biol.1995; 15: 5858-5867.","DOI":"10.1128\/MCB.15.11.5858"},{"key":"2020021300234298800_REF36","unstructured":"Koritschoner NP, Madruga J, Knespel S, et al. The nuclear orphan receptor TR4 promotes proliferation of myeloid progenitor cells. Cell Growth Differ. 2001;12: 563-572."},{"key":"2020021300234298800_REF37","doi-asserted-by":"crossref","unstructured":"Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol.1998;14: 167-196.","DOI":"10.1146\/annurev.cellbio.14.1.167"},{"key":"2020021300234298800_REF38","doi-asserted-by":"crossref","unstructured":"McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci.2002; 27: 40-47.","DOI":"10.1016\/S0968-0004(01)02031-X"},{"key":"2020021300234298800_REF39","doi-asserted-by":"crossref","unstructured":"Surinya KH, Cox TC, Masy B. Transcriptional regulation of the human erythroid 5-aminolevulinase synthase gene. J Biol Chem.1997;272: 26585-26594.","DOI":"10.1074\/jbc.272.42.26585"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/2\/698\/1688575\/h81403000698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/2\/698\/1688575\/h81403000698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T01:10:01Z","timestamp":1622941801000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/2\/698\/17386\/A-promoter-mutation-in-the-erythroidspecific"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-06-1623","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,15]]}}}